
Anthony Ranaudo
2015 • Topps
Series 1 • #240
The 2024 Topps Series 1 Jacob Amaya #144 baseball card features the Miami Marlins prospect in a standard rookie-year release.
2024 • Topps • Series 1
Major League Baseball • Miami Marlins
Near Mint
144
New
Shipping Calculated at Checkout
The 2024 Topps Series 1 Jacob Amaya #144 baseball card represents a key entry for collectors following the Miami Marlins' farm system. Released as part of the flagship 2024 Topps Series 1 set, this card highlights Amaya during a pivotal stage of his professional development. Collectors often seek out this card number to complete their base set or to track the progression of promising young talent within the MLB landscape. As a standard issue from one of the most recognized brands in the hobby, this card serves as a foundational piece for many baseball collections. Jacob Amaya's appearance in this set offers a snapshot of his career trajectory, allowing fans to preserve a moment in time as he navigates the competitive world of professional baseball. For those focused on team-specific collecting, this card is an essential addition for any Miami Marlins enthusiast building a comprehensive library. It provides a tangible connection to the organization's future prospects. Whether you are looking to fill a gap in your binder or acquire a card that symbolizes the next generation of MLB talent, this release offers a straightforward and classic approach to sports card collecting. The enduring appeal of Topps Series 1 lies in its consistency and historical significance within the hobby. Each year, collectors turn to this release to document the current state of the game, and the 2024 edition is no exception. By including the Jacob Amaya #144 card in your collection, you are participating in a long-standing tradition of documenting baseball history, one card at a time. This product remains a relevant and accessible option for anyone looking to expand their baseball holdings with a reputable and widely recognized brand.
45 minutes ago
We'll pre-fill the product details from this catalog entry, so your listing lands on this exact page. Just add photos of your copy, pick its condition, and set your price.
The catalog profile below summarizes the card identity, featured subject, and notable collectible traits.
The core identity of the card within the set.
The subject, team, league, and sport context tied to this card.
Production details and format-specific attributes.
Material
Card Stock
Language
English
Compare prices, grades, photos, and shipping from verified sellers
SuperCatch
New
Near Mint
See how many public collections currently include this card.
0 collectors have this card
Jacob Amaya's 2024 Topps Series 1 base card sits at the entry-level tier of his collectible market, consistent with a young MLB player still establishing his big-league footprint. As a Miami Marlins middle infielder with limited star recognition, this card trades in line with other low-profile Series 1 base cards rather than commanding any notable premium. The single active listing signals thin market activity, which can reflect either collector disinterest or a card that moves quickly when priced right.
This appears to be a standard base card with no noted parallels, serial numbering, or short-print designation, placing it in the highest print-run tier of the Series 1 release. Without autograph or relic variants noted, the population of raw copies far exceeds graded submissions, and PSA/BGS graded copies are likely minimal given the card's current market positioning. Collectors seeking scarcity would need to pursue the parallel rainbow — Gold, Independence Day, or Image Variation versions — to find meaningful print-run limitations.
Amaya's investment case hinges entirely on his development trajectory with Miami, a rebuilding franchise that has not consistently produced marketable stars in recent years. If he secures a starting role and posts strong offensive numbers, base rookie-year cards like this can see renewed interest, but grading submission trends for low-value base cards rarely justify the cost unless a breakout occurs. Patient collectors who acquire at current low-entry pricing carry minimal downside, though significant upside would require a clear on-field leap in performance and visibility.

2015 • Topps
Series 1 • #240

2015 • Topps
Series 1 • #209

2015 • Topps
Series 1 • #103

2015 • Topps
Series 1 • #97

2015 • Topps
Series 1 • #125